Literature DB >> 12218128

Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line.

Athena W Wong1, Nilanjan Ghosh, Karen P McKinnon, William Reed, Janet F Piskurich, Kenneth L Wright, Jenny P-Y Ting.   

Abstract

Although activated human T cells express MHC class II antigens, the regulation of these antigens in T cells is poorly understood. This study focuses on the control of the MHC2TA gene in these cells. MHC2TA encodes the transcriptional master regulator of MHC class II, the class II trans-activator (CIITA). It has at least three distinct promoters (PI, PIII, and PIV), each active in an overlapping subset of cell types and directing a slightly different product. This report used highly purified blood T cells prepared by negative immunoselection to analyze CIITA. Real-time PCR analysis indicates that resting T cells do not express detectable CIITA transcript, while activated T cells express the PIII CIITA form. Transient transfection of activated blood T cells using wild-type and mutant PIII promoter-reporter constructs shows that two promoter elements, activation response element-1 (ARE-1) and ARE-2, are important for PIII function. cAMP response element binding protein, a known activator of gene expression in activated T cells, activates PIII in primary T cells. However, an intact ARE-2 site is not required for this activation, indicating that cAMP response element binding protein does not activate via this site. EMSAs indicate that an activating transcription factor/cAMP response element binding protein/cAMP response element modulator family member, but not phosphorylated cAMP response element binding protein-1, binds to ARE-2. ARE-2 also forms a complex with an unidentified protein. The ARE-2 binding protein is constitutively expressed in a DR(+) T cell line, reflecting differences between the DR(+) cell line and primary blood lymphocytes. These results show that MHC2TA PIII is induced in activated T lymphocytes, and that the induced binding of ARE-2 is a crucial step in this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218128     DOI: 10.4049/jimmunol.169.6.3112

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  ATG deserts define a novel core promoter subclass.

Authors:  Maxwell P Lee; Kevin Howcroft; Aparna Kotekar; Howard H Yang; Kenneth H Buetow; Dinah S Singer
Journal:  Genome Res       Date:  2005-08-18       Impact factor: 9.043

2.  Global functional analysis of nucleophosmin in Taxol response, cancer, chromatin regulation, and ribosomal DNA transcription.

Authors:  Daniel T Bergstralh; Brian J Conti; Chris B Moore; W June Brickey; Debra J Taxman; Jenny P-Y Ting
Journal:  Exp Cell Res       Date:  2006-09-26       Impact factor: 3.905

3.  Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.

Authors:  Eleni Zika; Lucas Fauquier; Laurence Vandel; Jenny P-Y Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-27       Impact factor: 11.205

4.  Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.

Authors:  Janet F Piskurich; Carolyn A Gilbert; Brittany D Ashley; Mojun Zhao; Han Chen; Jian Wu; Sophia C Bolick; Kenneth L Wright
Journal:  Mol Immunol       Date:  2005-06-13       Impact factor: 4.407

5.  Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.

Authors:  Andrew W Lee; Nan Wang; Tara M C Hornell; James J Harding; Chetan Deshpande; Laura Hertel; Vashti Lacaille; Achal Pashine; Claudia Macaubas; Edward S Mocarski; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2011-03-31       Impact factor: 4.407

6.  Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B.

Authors:  Ying-Ren Zhao; Ling Gong; Ying-Li He; Fang Liu; Chang Lu
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

7.  NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.

Authors:  Torsten B Meissner; Yuen-Joyce Liu; Kyoung-Hee Lee; Amy Li; Amlan Biswas; Marja C J A van Eggermond; Peter J van den Elsen; Koichi S Kobayashi
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

8.  Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region.

Authors:  Erik Schooten; Petra Klous; Peter J van den Elsen; Tjadine M Holling
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

9.  Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.

Authors:  Eleni Zika; Susanna F Greer; Xin-Sheng Zhu; Jenny P-Y Ting
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.

Authors:  Agnieszka D Truax; Meghna Thakkar; Susanna F Greer
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.